MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹7,420 Cr | ₹187 Cr | ₹199 Cr | ₹169 Cr | ₹107 Cr |
What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹7,420 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹169 Cr |
| Mar2021 | ₹107 Cr |
How is Total Non-Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,420 Cr | 3,860.66 | |
| Mar2024 | ₹187 Cr | -5.97 | |
| Mar2023 | ₹199 Cr | 18.12 | |
| Mar2022 | ₹169 Cr | 57.15 | |
| Mar2021 | ₹107 Cr | - | |
Compare Total Non-Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹86,450.6 Cr | -1.4% | -4.6% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.4% |
-4.6% |
-18% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses